Instituto de Medicina Molecular donations received

This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of July 2024. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.

Table of contents

Basic donee information

ItemValue
Country
Wikipedia pagehttps://en.wikipedia.org/wiki/Instituto_de_Medicina_Molecular

Donee donation statistics

Cause areaCountMedianMeanMinimum10th percentile 20th percentile 30th percentile 40th percentile 50th percentile 60th percentile 70th percentile 80th percentile 90th percentile Maximum
Overall 5 138,865 378,416 100,000 100,000 100,000 100,000 100,000 138,865 138,865 334,388 334,388 1,218,825 1,218,825
Global health 5 138,865 378,416 100,000 100,000 100,000 100,000 100,000 138,865 138,865 334,388 334,388 1,218,825 1,218,825

Donation amounts by donor and year for donee Instituto de Medicina Molecular

Donor Total 2015 2014 2013 2010
Bill and Melinda Gates Foundation (filter this donee) 1,892,078.00 334,388.00 138,865.00 1,318,825.00 100,000.00
Total 1,892,078.00 334,388.00 138,865.00 1,318,825.00 100,000.00

Full list of documents in reverse chronological order (0 documents)

There are no documents associated with this donee.

Full list of donations in reverse chronological order (5 donations)

Graph of top 10 donors (for donations with known year of donation) by amount, showing the timeframe of donations

Graph of donations and their timeframes
DonorAmount (current USD)Amount rank (out of 5)Donation dateCause areaURLInfluencerNotes
Bill and Melinda Gates Foundation334,388.0022015-02-26Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to develop a vaccine against malaria, based on the use of Plasmodium berghei rodent malaria parasites as a platform for the delivery of immunogenic antigens of human-infective Plasmodia; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation138,865.0032014-09-18Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to develop a vaccine against malaria, based on the use of Plasmodium berghei rodent malaria parasites as a platform for the delivery of immunogenic antigens of human-infective Plasmodia; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation1,218,825.0012013-10-08Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to develop a vaccine against malaria, based on the use of Plasmodium berghei rodent malaria parasites as a platform for the delivery of immunogenic antigens of human-infective Plasmodia; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation100,000.0042013-04-10Global health/malariahttps://iatiregistry.org/publisher/bmgf-- To identify drugs that potentially provide long-lasting protection against malaria by screening for compounds that specifically block the final liver maturation stage of the causative Plasmodium parasites.; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation100,000.0042010-09-21Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to test the theory that modified live rodent malaria parasites (P. berghei) can be used in a vaccine to elicit a strong immune response in humans without being able to infect human red blood cells and cause illness; Aid type: Project-type interventions. Affected regions: South of Sahara.